Medesthetics

SEP 2014

MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.

Issue link: https://medesthetics.epubxp.com/i/367774

Contents of this Issue

Navigation

Page 10 of 82

BEST PR ACTICES 6 SEPTEMBER 2014 | Med Esthetics The ultrasound-based Ulthera System has received FDA clearance for the noninvasive treatment of lines and wrinkles on the chest or décolleté. The Ultherapy Décolletage Treatment takes about 30 minutes to perform with no downtime, and stimulates the natural formation of collagen and elastin in the skin's foundation to gradually smooth chest wrinkles. Treatment results are visible after about three months. "The décolleté indication fi lls a very clear void for patients and reinforces our commitment to expanding our platform technology. Our goal is to reward Ultherapy practices by bringing more value to the Ulthera System during each year of owner- ship," said Matthew E. Likens, president and CEO of Ulthera. "Now, the Ultherapy Treatment addresses four total treatment areas—from the brow to the chest." Ultherapy Approved for Décolleté Rejuvenation Your front desk employees are the fi rst point of contact for new patients. Their skills—both on the phone and in the waiting area—can help increase bookings and improve overall patient satisfaction. To help practices better train their front desk staff members, Laurie Mercer, senior practice consultant with Allergan, shared the most common mistakes made by front desk staff as part of her presentation at the American Academy of Facial Plastic and Reconstructive Surgery (A AFPRS) meeting in May. They include: • Not answering the phone in one to two rings. • Not giving his or her name and the practice's name when answering. • Not asking for—and using—the caller's name. • Putting callers on hold without asking permission. • Not asking callers how they heard about the practice. • Not asking questions and quoting prices too early. • Not explaining what makes your practice unique. • Not greeting patients with a warm welcome when they arrive. • Not recognizing that patients in the waiting room are watching and listening to staff. The U.S. Food and Drug Administration (FDA) has issued marketing clearance for Restylane Silk Injectable Gel with 0.3% lidocaine (Galderma Laboratories) for submucosal implantation in lip augmentation and dermal implantation to correct perioral rhytids in patients over 21. The clinical study—conducted to evaluate the safety and effectiveness of injections to enhance lip fullness and improve wrinkles around the lips—included 221 mostly female subjects. Of those subjects, 98% reported improvement in their lip fullness 14 days after injection, and 76% still had lip improvement six months later. The majority of adverse events were mild in intensity, and the most common symptoms were lip swelling, contusion and lip pain. The incidence of adverse events decreased signifi cantly after the second treatment. Before After Restylane Silk Approved for Lip Augmentation Front Desk Misses IMAGE COURTESY OF STEVEN DAYAN, MD; © GETTY IMAGES

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - SEP 2014